A Practical Diagnostic Framework for Hepatic Encephalopathy : Hepatology | June 2026

Introduction:

Hepatic encephalopathy (HE) is one of the most common and debilitating neuropsychiatric complications of liver disease and portal-systemic shunting. It can present with a broad spectrum of manifestations, ranging from subtle cognitive impairment to profound coma, significantly affecting quality of life, healthcare utilization, and survival. Although ammonia plays a central role in its pathogenesis, growing evidence supports a multifactorial process involving gut-derived inflammation, infection, and neuroinflammatory pathways.

Problem Statement:

Diagnosing HE remains challenging because there is no single definitive diagnostic test. Patients with cirrhosis and portal hypertension are also susceptible to numerous alternative causes of altered mental status, many of which are potentially reversible and require urgent treatment. Consequently, HE remains a diagnosis of exclusion, demanding a structured and systematic clinical approach to avoid misdiagnosis and delayed management.

Summary:

This review provides a practical framework for the diagnosis of HE in both acute and outpatient settings. The authors emphasize that accurate diagnosis begins with confirmation of the underlying liver disease or portal-systemic shunting capable of causing HE. Clinical characterization is then essential, recognizing the diverse cognitive, behavioral, neurological, and consciousness-related manifestations that may occur. The review highlights the importance of actively searching for precipitating factors, including infection, gastrointestinal bleeding, constipation, dehydration, electrolyte disturbances, renal dysfunction, and medication-related triggers, as correction of these factors often leads to clinical improvement. Equally important is the systematic exclusion of alternative neurological, metabolic, infectious, psychiatric, and toxicological causes of altered mental status. The authors propose a practical four-step diagnostic approach: defining the underlying disease, characterizing the clinical syndrome, identifying precipitants and risk factors, and excluding competing diagnoses. For patients with subtle cognitive dysfunction, the review also discusses the role of neuropsychological and neurophysiological testing in the diagnosis of covert HE. This structured approach provides clinicians with a clinically relevant roadmap for diagnosing HE, ensuring timely recognition while minimizing the risk of overlooking other potentially treatable conditions.